for more information visit www.camenaegroup.com
or call 817.788.0017

PROGRAM
FACULTY

 

Jacqueline G. O’Leary, MD, MPH

Program Co-Chair

Medical Director of the Liver and Transplant Unit

Baylor University Medical Center

Dallas, Texas

 

Luis Lara, MD

Program Co-Chair

Division of Gastroenterology

Baylor University Medical Center

Dallas, Texas

 

Gary L. Davis, MD

Director of General and Transplant Hepatology

Baylor Health Care System Baylor Regional Transplant Institute

Dallas, Texas

 

Daniel DeMarco, MD, FACP, FACG, AGAF

Director of Endoscopy

Baylor University Medical Center

Dallas, Texas

 

Stevan Gonzalez, MD, MS

Division of Hepatology

Baylor University Medical Center

Dallas, Texas

 

Colleen I. Kennedy, MD

General and Bariatric Surgery

Kennedy Bariatrics

Dallas, Texas

 

Carmen E. Landaverde, MD

Division of Hepatology

Baylor University Medical Center

Dallas, Texas

 

Rita Lepe, MD

Division of Hepatology

Baylor University Medical Center

Dallas, Texas

 

Marlon Levy, MD, FACS

Surgical Director, Transplantation

Baylor All Saints Medical Center

Fort Worth, Texas

 

Natalie G. B. Murray, MD

Medical Director Liver Transplantation

Baylor All Saints Medical Center

Fort Worth, Texas

 

Elizabeth Odstrcil, MD

Division of Gastroenterology

Baylor University Medical Center

Dallas, Texas

 

Robert P. Perrillo, MD

Division of Hepatology

Baylor University Medical Center

Dallas, Texas

 

James F. Trotter, MD

Medical Director of Liver Transplantation
Baylor University Medical Center

Dallas, Texas

 

Jennifer T. Wells, MD

Division of Hepatology

Baylor University Medical Center

Dallas, Texas

 

 

 

 


This program is supported by:

Bayer/Onyx

Genentech/Roche

Otsuka

Vertex

Biotest

Bristol-Myers Squibb

Gilead Sciences, Inc.

Salix Pharmaceuticals

Astellas Pharma

Merck/Schering Plough

Three Rivers Pharmaceuticals

Novartis

 

 

 

Click here to download Course Syllabus

OVERVIEW

Gastroenterology and Hepatology RoundUp 2010, our sixth annual, is designed to update providers in gastroenterology and hepatology on new approaches to the diagnosis and management of gastrointestinal and liver diseases.

TARGET AUDIENCE

This course is specifically targeted towards Gastroenterologists, Hepatologists, Family Practitioners, Nurse Practitioners, Internists, Surgeons, Physician Assistants, Registered Nurses and Clinical Transplant Nurses & Coordinators.

OBJECTIVES

Upon completion of this activity, participants should be able to:

  • Delineate the side effects, dosing intervals, and resistance potential of direct acting antiviral therapies in phase 3 clinical trials that will be available for clinical use for hepatitis C.

  • Appropriately identify and manage patients with chronic hepatitis B virus infection.

  • Define the benefits and complications of different surgical options for weight loss in NASH patients.

  • Summarize updates on current standards of care regarding management of cirrhosis complications, particularly transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites and vasopressin antagonist therapy for hyponatremia.

  • Interpret screening guidelines and appropriate treatment options for hepatocellular carcinoma.

  • Utilize B-blockade and banding to obliteration as primary prophylaxis for variceal hemorrhage.

  • Synthesize the indications for endoscopy in evaluation of small bowel pathology with the endoscopic methods now available.

  • Improve colorectal neoplasia detection rates through CT enterography, DNA stool sampling and third eye retroscope.

  • Compare and contrast medical vs. surgical treatment options for chronic pancreatitis.

  • Through the use of case studies, formulate diagnoses, appropriate treatment plans and follow up guided by an expert panel.

AGENDA

7:30 AM  Registration / Continental Breakfast     Exhibits

8:00 AM  Program Overview
Gary Davis, MD

8:10 AM  Hepatitis C Therapy: Using Direct Acting Antiviral Drugs
 Gary Davis, MD

8:30 AM  Q&A
Moderator: Gary Davis, MD

8:40 AM  Hepatitis B Therapy: Treating Patients with “Normal” ALTs
 Robert Perrillo, MD

9:00 AM  Q&A
Moderator: Gary Davis, MD

9:10 AM  DEBATE & PANEL DISCUSSION:
Role of Medical vs. Surgical Treatment of NASH
 Rita Lepe, MD
Colleen Kennedy, MD

9:40 AM  Q&A
Moderator: Gary Davis, MD

9:50 AM Break and Exhibits

10:10 AM Managing Refractory Ascites and Hyponatremia
Jacqueline O’Leary, MD MPH

10:30 AM Q&A
Moderator: Jacqueline O’Leary, MD MPH

10:40 AM Hepatocellular Carcinoma: Choosing the Best Treatment
 Jennifer Wells, MD

11:00 AM Q&A
Moderator: Jacqueline O’Leary, MD MPH

11:10 AM DEBATE & PANEL DISCUSSION:
 Primary Prophylaxis for Variceal Hemorrhage: To Band or Not to Band?
 James Trotter, MD
Steve Gonzalez, MD MS

11:40 AM CASE STUDIES
 Natalie G. B. Murray, MD
Stevan Gonzalez, MD, MS
Carmen Landaverde, MD
 Moderator: Jacqueline O’Leary, MD MPH

12:00 PM Lunch and Exhibits

12:50 PM Conquering the Lumenal Frontier: Capsule Endoscopy and Overtube Assisted Enteroscopy
 Daniel DeMarco, MD

1:10 PM   Q&A
Moderator: Luis Lara, MD

1:20 PM   Improving Colorectal Neoplasia Detection: CT Enterography, DNA Stool Sampling and The Third Eye Retroscope
 Elizabeth Odstrcil, MD

1:40 PM   Q&A
Moderator: Luis Lara, MD

1:50 PM   DEBATE & PANEL DISCUSSION:
Chronic Pancreatitis: Should the 3 Rules of Surgery Apply? Medical vs. Surgical Treatment
 Luis Lara, MD
Marlon Levy, MD

2:20 PM   Closing Remarks / Adjourn

 

VENUE

The Ritz-Carlton Hotel
 2121 McKinney Avenue, Dallas, Texas 75201    Phone:  (214) 922-0200

Experience a stylish, contemporary, accessible downtown Dallas hotel -- where graciousness and the Texas spirit meet. The Ritz-Carlton, Dallas is ideally located in the picturesque enclave of Uptown Dallas on the McKinney Avenue Trolley Line. The city’s most popular visitor zone, Uptown is host to gourmet dining, upscale shopping, sightseeing and galleries, and the largest urban arts community in the United States. 

Conference attendees wishing to stay at the Ritz-Carlton, Dallas may make room reservations by calling the hotel toll-free at 800-542-8680.


CONTINUING EDUCATION CREDIT

PHYSICIAN ACCREDITATION & CREDIT DESIGNATION STATEMENTS

This activity was planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the A. Webb Roberts Center for Continuing Education of Baylor Health Care System, Dallas, and The Camenae Group, Inc. The A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, is accredited by the ACCME to provide continuing medical education for physicians.

The A. Webb Roberts Center for Continuing Education of Baylor Health Care System, Dallas, designates this educational activity for a maximum of 5.0 AMA PRA Category 1 credits.(TM) Physicians should only claim credit commensurate with the extent of their participation in the activity.

NURSING ACCREDITATION

Accreditation Statement
The Camenae Group, Inc. is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides 5.0 contact hours.

AMERICAN BOARD FOR TRANSPLANT CERTIFICATION (Clinical Transplant Nurse, Clinical Transplant Coordinator)

The ABTC has granted a total of 5.0 Category III Continuing Education Points for Transplant Certification (CEPTCs) to the Hepatology and GI Roundup.

NURSE PRACTITIONER ACCREDITATION

This program is approved for 5.0 contact hours of continuing education by the American Academy of Nurse Practitioners. Program ID 1008261.

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.